Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael R Johnson

Showing results (81-90 of 105) with videos related to

Pageof 11
Sort By:
Frontiers in Pharmacology|June 28, 2021
Role of Common Genetic Variants for Drug-Resistance to Specific Anti-Seizure MedicationsStefan Wolking, Ciarán Campbell, Caragh Stapleton, et al.
Brain : a Journal of Neurology|September 10, 2013
Faciobrachial dystonic seizures: the influence of immunotherapy on seizure control and prevention of cognitive impairment in a broadening phenotypeSarosh R Irani, Charlotte J Stagg, Jonathan M Schott, et al.
Plos One|December 9, 2021
An assessment of marine, estuarine, and riverine habitat vulnerability to climate change in the Northeast U.SEmily R Farr, Michael R Johnson, Mark W Nelson, et al.
Annals of Clinical and Translational Neurology|May 21, 2021
Assessing the role of rare genetic variants in drug-resistant, non-lesional focal epilepsyStefan Wolking, Claudia Moreau, Mark McCormack, et al.
Nature Communications|September 5, 2018
A systems-level framework for drug discovery identifies Csf1R as an anti-epileptic drug targetPrashant K Srivastava, Jonathan van Eyll, Patrice Godard, et al.
Epilepsia Open|March 15, 2019
A genome-wide association study of sodium levels and drug metabolism in an epilepsy cohort treated with carbamazepine and oxcarbazepineBianca Berghuis, Caragh Stapleton, Anja C M Sonsma, et al.
Frontiers in Neuroscience|October 4, 2023
Testing for pharmacogenomic predictors of ppRNFL thinning in individuals exposed to vigabatrinIsabelle Boothman, Lisa M Clayton, Mark McCormack, et al.
Epilepsia Open|December 11, 2019
Genomic and clinical predictors of lacosamide response in refractory epilepsiesSinéad B Heavin, Mark McCormack, Stefan Wolking, et al.
Human Molecular Genetics|August 22, 2013
A genome-wide association study and biological pathway analysis of epilepsy prognosis in a prospective cohort of newly treated epilepsyDoug Speed, Clive Hoggart, Slave Petrovski, et al.
Epileptic Disorders : International Epilepsy Journal with Videotape|May 26, 2007
Genetics of epilepsy: epilepsy research foundation workshop reportSanjay Sisodiya, J Helen Cross, Ingmar Blümcke, et al.
Pageof 11

Showing results (81-90 of 105) with videos related to

Sort By:
Pageof 11
Frontiers in Pharmacology|June 28, 2021
Role of Common Genetic Variants for Drug-Resistance to Specific Anti-Seizure MedicationsStefan Wolking, Ciarán Campbell, Caragh Stapleton, et al.
Brain : a Journal of Neurology|September 10, 2013
Faciobrachial dystonic seizures: the influence of immunotherapy on seizure control and prevention of cognitive impairment in a broadening phenotypeSarosh R Irani, Charlotte J Stagg, Jonathan M Schott, et al.
Plos One|December 9, 2021
An assessment of marine, estuarine, and riverine habitat vulnerability to climate change in the Northeast U.SEmily R Farr, Michael R Johnson, Mark W Nelson, et al.
Annals of Clinical and Translational Neurology|May 21, 2021
Assessing the role of rare genetic variants in drug-resistant, non-lesional focal epilepsyStefan Wolking, Claudia Moreau, Mark McCormack, et al.
Nature Communications|September 5, 2018
A systems-level framework for drug discovery identifies Csf1R as an anti-epileptic drug targetPrashant K Srivastava, Jonathan van Eyll, Patrice Godard, et al.
Epilepsia Open|March 15, 2019
A genome-wide association study of sodium levels and drug metabolism in an epilepsy cohort treated with carbamazepine and oxcarbazepineBianca Berghuis, Caragh Stapleton, Anja C M Sonsma, et al.
Frontiers in Neuroscience|October 4, 2023
Testing for pharmacogenomic predictors of ppRNFL thinning in individuals exposed to vigabatrinIsabelle Boothman, Lisa M Clayton, Mark McCormack, et al.
Epilepsia Open|December 11, 2019
Genomic and clinical predictors of lacosamide response in refractory epilepsiesSinéad B Heavin, Mark McCormack, Stefan Wolking, et al.
Human Molecular Genetics|August 22, 2013
A genome-wide association study and biological pathway analysis of epilepsy prognosis in a prospective cohort of newly treated epilepsyDoug Speed, Clive Hoggart, Slave Petrovski, et al.
Epileptic Disorders : International Epilepsy Journal with Videotape|May 26, 2007
Genetics of epilepsy: epilepsy research foundation workshop reportSanjay Sisodiya, J Helen Cross, Ingmar Blümcke, et al.
Pageof 11